Topamax
Product Images NDC 21695-128

6 FDA label images from Rebel Distributors Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Topamax (NDC 21695-128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (202b1a2a 11dc 4c3d Aa53 27512a98a042 01)

Chemical Structure (202b1a2a 11dc 4c3d Aa53 27512a98a042 01)
Chemical structure diagram of the active ingredient in Topamax, showing a sugar-like ring with multiple oxygen atoms and side chains including methyl groups and a methanesulfonamide group attached.*
FDA Label Image

Figure (202b1a2a 11dc 4c3d Aa53 27512a98a042 02)

Figure (202b1a2a 11dc 4c3d Aa53 27512a98a042 02)
A cumulative rate plot showing time to first seizure for Topiramate at doses of 50 mg/day and 400 mg/day. The graph compares two groups with sample sizes indicated, displaying seizure incidence over time in days, with a statistical significance p-value noted.*
FDA Label Image

Figure (202b1a2a 11dc 4c3d Aa53 27512a98a042 03)

Figure (202b1a2a 11dc 4c3d Aa53 27512a98a042 03)
A bar chart comparing the change from baseline to double-blind phase in average monthly migraine period rate (± SE) across different Topamax dosages (50 mg/day, 100 mg/day, 200 mg/day) and placebo groups. The chart differentiates between two studies labeled TOPMAT-MIGR-001 and TOPMAT-MIGR-002, showing statistically significant reductions in migraine rates for Topamax, especially at higher doses.*
FDA Label Image

Topamax 25 mg (202b1a2a 11dc 4c3d Aa53 27512a98a042 04)

Topamax 25 mg (202b1a2a 11dc 4c3d Aa53 27512a98a042 04)
Topamax 25mg tablets packaging label from Rebel Distributors Corp, showing 15 tablets. The label displays the product name, strength, dosage form, NDC number 21695-128-15, and indicates Rx Only. It includes manufacturer information (Ortho-McNeil Pharmaceutical Inc.) and storage instructions to keep at controlled room temperature 15-30°C (59-86°F).*
FDA Label Image

Topamax 50 mg (202b1a2a 11dc 4c3d Aa53 27512a98a042 05)

Topamax 50 mg (202b1a2a 11dc 4c3d Aa53 27512a98a042 05)
Topamax 50 mg tablets packaging label from Physician Partner. The label shows the proprietary name Topamax, strength 50 mg, and quantity #15 tablets. It includes the NDC 21695-129-15 and mentions that each tablet contains topiramate 50 mg. The label notes the product ID PT012915 and states the product is RX only. It also includes manufacturer's information, lot and expiration placeholders, and storage instructions at controlled room temperature.*
FDA Label Image

Topamax 100 mg (202b1a2a 11dc 4c3d Aa53 27512a98a042 06)

Topamax 100 mg (202b1a2a 11dc 4c3d Aa53 27512a98a042 06)
Topamax 100 mg tablets packaging label displaying 15 tablets per bottle. The label indicates the product ID PT013015 and lists Ortho-McNeil Pharmaceutical Inc. as the manufacturer. It includes instructions that the tablets are yellow, round, coated, and debossed with "TOPAMAX" on one side and "100" on the other. The label is branded by Physician Partner and includes storage instructions and a reference to the NDC 21695-130-15.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.